Business Standard

Sunday, December 22, 2024 | 06:53 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Govt issues scheme guidelines to boost drug manufacturing, medical devices

The objective is to make India self reliant in production of 53 critical Active Pharmaceutical Ingredients, and in production of medical devices, for which India is crucially dependent on imports

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

Eligible manufacturers will be selected for the PLI scheme on the basis of marks obtained in the evaluation criteria as per the guidelines

Press Trust of India New Delhi
The government on Monday released guidelines of four schemes for the development of bulk drug and medical device parks in the country to promote their domestic manufacturing.

"In line with the vision of Prime Minister Shri Narendra Modi, the schemes have been conceptualised for making India 'Atmanirbhar' in the pharma sector," Union Minister of Chemicals and Fertilisers D V Sadananda Gowda said.

The objective is to make India self reliant in production of 53 critical Active Pharmaceutical Ingredients (APIs) or Key Starting Materials (KSMs), and in production of medical devices, for which India is crucially dependent on imports, he said

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in